1. Home
  2. KLTOW vs CCLDO Comparison

KLTOW vs CCLDO Comparison

Compare KLTOW & CCLDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • CCLDO
  • Stock Information
  • Founded
  • KLTOW N/A
  • CCLDO N/A
  • Country
  • KLTOW United States
  • CCLDO United States
  • Employees
  • KLTOW 3
  • CCLDO 3650
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • CCLDO Computer Software: Prepackaged Software
  • Sector
  • KLTOW Health Care
  • CCLDO Technology
  • Exchange
  • KLTOW Nasdaq
  • CCLDO Nasdaq
  • Market Cap
  • KLTOW N/A
  • CCLDO N/A
  • IPO Year
  • KLTOW 2022
  • CCLDO N/A
  • Fundamental
  • Price
  • KLTOW $0.02
  • CCLDO $19.68
  • Analyst Decision
  • KLTOW
  • CCLDO
  • Analyst Count
  • KLTOW 0
  • CCLDO 0
  • Target Price
  • KLTOW N/A
  • CCLDO N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • CCLDO N/A
  • Earning Date
  • KLTOW N/A
  • CCLDO N/A
  • Dividend Yield
  • KLTOW N/A
  • CCLDO N/A
  • EPS Growth
  • KLTOW N/A
  • CCLDO N/A
  • EPS
  • KLTOW N/A
  • CCLDO N/A
  • Revenue
  • KLTOW N/A
  • CCLDO N/A
  • Revenue This Year
  • KLTOW N/A
  • CCLDO N/A
  • Revenue Next Year
  • KLTOW N/A
  • CCLDO N/A
  • P/E Ratio
  • KLTOW N/A
  • CCLDO N/A
  • Revenue Growth
  • KLTOW N/A
  • CCLDO N/A
  • 52 Week Low
  • KLTOW N/A
  • CCLDO N/A
  • 52 Week High
  • KLTOW N/A
  • CCLDO N/A
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • CCLDO 64.71
  • Support Level
  • KLTOW N/A
  • CCLDO $17.50
  • Resistance Level
  • KLTOW N/A
  • CCLDO $18.70
  • Average True Range (ATR)
  • KLTOW 0.00
  • CCLDO 0.39
  • MACD
  • KLTOW 0.00
  • CCLDO 0.20
  • Stochastic Oscillator
  • KLTOW 0.00
  • CCLDO 87.55

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CCLDO CareCloud Inc.

CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

Share on Social Networks: